Clinical Trial Update: Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

View source ↗

Summary

Long-term follow-up study update for participants in any iECURE protocol using an investigational product; the trial remains in RECRUITING status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ornithine Transcarbamylase Deficiency
• Urea Cycle Disorders Inborn

Drugs mentioned

• Investigational product (IP) used in iECURE protocols

Snippet

Sponsor: iECURE, Inc. | Conditions: Ornithine Transcarbamylase Deficiency, Ornithine Transcarbamylase Deficiency Disease | Status: RECRUITING